Hormetic ER Stress Regulation of Hematopoietic Stem Cell Function
造血干细胞功能的激效内质网应激调节
基本信息
- 批准号:10624420
- 负责人:
- 金额:$ 49.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-03 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAntioxidantsApoptoticBCL2 geneBiochemicalBiological AssayBloodBlood CellsBlood PlateletsBlood coagulationBone MarrowBone Marrow CellsCa(2+)-Transporting ATPaseCalciumCell CountCell LineageCell MaintenanceCell membraneCell physiologyCellsChIP-seqCharacteristicsCulture MediaCuriositiesDataDevelopmentDoseEndoplasmic ReticulumEndowmentEngraftmentEnvironmentEpigenetic ProcessErythrocytesExhibitsFeedbackFormulationFutureGenesGenetic TranscriptionGlycolysisGlycolysis InhibitionGoalsHematologic NeoplasmsHematological DiseaseHematopoiesisHematopoietic NeoplasmsHematopoietic stem cellsHomeostasisHumanITPR1 geneImmuneIn VitroIndividualIntercellular FluidKnockout MiceLeukocytesLipidsLiteratureLongevityMaintenanceMediatingMethodsMitochondriaMitochondrial ProteinsMolecularMouse StrainsMusNuclearOutputOxidation-ReductionPathway interactionsPatientsPersonsPhenotypePhysiologicalPopulationProcessProductionProteinsPublishingRegulationReporterReportingResearchRespirationRoleSignal PathwaySignal TransductionSignal Transduction PathwaySourceStressTerminal DiseaseTestingTherapeuticTranslatingTransplantationUmbilical Cord BloodUp-Regulationbiological adaptation to stresscell agecell typeclinical applicationclinically relevantcytokineefflux pumpendoplasmic reticulum stressexperimental studyextracellularfluorophoregene functionhematopoietic stem cell expansionhematopoietic stem cell self-renewalhuman stem cellsimprovedin vivoinsightmitochondrial metabolismnovelpreservationpreventprogenitorprogramsresponseself-renewalstemstem cell biologystem cell functionstem cell self renewalstem cellsstemnesstissue culturetranscriptome sequencingtranscriptomicstranslational potential
项目摘要
Project Summary
Hematopoiesis involves the continuous production of red blood cells (erythrocytes), immune cells (leukocytes)
and blood clotting platelets over the lifespan of the subject all of which are derived from hematopoietic stem cells
(HSCs) located in bone marrow. HSCs have two critical characteristics - multipotency and self-renewal. A
complete picture of the molecular mechanisms regulating homeostatic output of blood from HSCs in vivo has
not yet emerged. Our published findings show HSCs are endowed with low intracellular calcium (Ca2+)
compared to bone marrow (BM) progenitor and lineage cells. We hypothesized a reduced extracellular calcium
environment, such as a low CaCl2 culture media, might improve HSC function. Remarkably, reduced CaCl2
media dramatically increased phenotypic HSC counts in long-term cultures and demonstrated a 20-fold increase
in long-term donor engraftment compared to classical CaCl2 media formulation, suggesting functionally potent
HSCs are maintained in low CaCl2. We demonstrated that HSC maintain low Ca2+ levels via high expression
and activity of plasma membrane calcium efflux pumps (PMCA) and reduced bone marrow interstitial fluid CaCl2
levels. Reduced CaCl2 decreased mitochondrial respiration, but not glycolysis, specifically in HSCs, while
inhibition of glycolysis elevated HSC Ca2+. These results demonstrate a positive feedback mechanism whereby
glycolytic PMCA Ca2+ efflux activity reduces Ca2+ and prevents mitochondrial respiration and promotes
glycolysis. Curiously, we showed mitochondrial mass is highest in HSCs suggesting an important, albiet
respiration-independent, role in HSCs. Building on these findings, literature suggests reduced CaCl2 can induce
ER stress. We observed Bcl-2 exhibits a dose-dependent upregulation under reduced CaCl2 culture conditions
in HSCs, suggesting induction of a pro-survival gene program. Regulators of the antioxidant genes known to be
induced by ER stress, including ATF4 and Nrf2, mediate upregulation of antioxidant genes including Bcl-2. We
found ATF4 and Nrf2 were also high expressed in HSCs in low CaCl2 culture. Therefore, we hypothesize that
reduced CaCl2 induces a hormetic ER stress response that supports HSC maintenance in vitro. We propose to
study what types of ER stresses occur and which unfolded protein response (UPR) signaling path branches are
activated in response low CaCl2. We propose to characterize the transcriptional program regulated by the PERK
branch of UPR, which activates the Atf4/Nrf2 ER stress response programs, that we have identified to be active.
Further, we propose to study the upregulation of Bcl-2 in HSCs under low CaCl2 conditions to determine if a
non-canonical role for Bcl-2 inhibits IP3R release of Ca2+ from luminal ER Ca2+ stores in HSCs. Furthermore,
we propose to corroborate these findings in human CB HSCs to accelerate translational potential of the findings.
This would establish a novel positive feedback loop required to reduce Ca2+ levels and preserve self-renewal
and multipotency in HSCs. These findings will expand our fundamental understanding of HSC biology and may
inspire methods to improve HSC expansion for clinical applications.
项目摘要
造血包括不断产生红细胞(红细胞)、免疫细胞(白细胞)。
在受试者的整个生命周期内凝血的血小板,所有这些都来自于造血干细胞
(HSCs)位于骨髓中。造血干细胞具有两个重要特征--多能性和自我更新。一个
调节体内HSCs的血液平衡输出的分子机制的完整图景
还没有出现。我们发表的研究结果表明,肝星状细胞具有低细胞内钙(钙)。
与骨髓(BM)祖细胞和谱系细胞相比。我们假设细胞外钙离子减少
环境,如低CaCl2培养基可改善HSC的功能。值得注意的是,减少了CaCl2
在长期培养中,培养基显着增加了表型HSC的数量,并表现出20倍的增长
在长期供体植入方面与经典的CaCl2介质配方进行比较,表明功能强大
肝星状细胞维持在低CaCl2状态。我们证明HSC通过高表达维持低钙水平。
和质膜钙外排泵(PMCA)和还原的骨髓间质液CaCl2的活性
级别。减少CaCl2会降低线粒体呼吸,但不会减少糖酵解,特别是在HSCs中,而
抑制糖酵解可使HSC钙离子水平升高。这些结果证明了一种正反馈机制,
糖酵解PMCA钙外流活性降低钙离子,阻止线粒体呼吸,促进
糖酵解。奇怪的是,我们发现在造血干细胞中线粒体质量最高,这表明了一种重要的白化现象
不依赖呼吸,在HSCs中的作用。基于这些发现,文献表明,减少CaCl2可以诱导
急诊室压力。我们观察到在还原的CaCl2培养条件下,bc l-2呈剂量依赖性上调。
在HSCs中,这表明诱导了有利于生存的基因程序。已知的抗氧化基因的调节者
内质网应激诱导包括ATF4和Nrf2在内的抗氧化剂基因表达上调。我们
发现在低CaCl2培养条件下,ATF4和Nrf2在HSC中也有高表达。因此,我们假设
减少CaCl2诱导激动型内质网应激反应,支持HSC在体外的维持。我们建议
研究发生了哪些类型的内质网应激,以及哪些未折叠蛋白反应(UPR)信号通路分支
在低CaCl2的情况下被激活。我们建议对受PERK调控的转录程序进行表征
UPR的分支,它激活ATF4/Nrf2 ER应激反应程序,我们已经确定它是活跃的。
此外,我们建议研究在低CaCl2条件下HSCs中Bcl2的上调,以确定是否有
Bcl2的非典范作用抑制HSCs内质网钙库钙离子的IP3R释放。此外,
我们建议在人类脐带血造血干细胞中证实这些发现,以加速这些发现的翻译潜力。
这将建立一个新的正反馈环路,需要降低钙水平和保持自我更新
和造血干细胞的多能性。这些发现将扩大我们对HSC生物学的基本理解,并可能
启发改进HSC扩增的方法,用于临床应用。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hormetic endoplasmic reticulum stress in hematopoietic stem cells.
- DOI:10.1097/moh.0000000000000668
- 发表时间:2021-11-01
- 期刊:
- 影响因子:3.2
- 作者:Luchsinger LL
- 通讯作者:Luchsinger LL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Larry L Luchsinger其他文献
Recovery of Highly Functional Human Hematopoietic Stem and Progenitor Cells from 27-Year Old Cryopreserved Umbilical Cord Blood
- DOI:
10.1182/blood-2022-170272 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Hal E. Broxmeyer;Larry L Luchsinger;Rona S Weinberg;Alexandra Jimenez;Emeline Masson Frenet;Mark Kaplan;Scott Cooper;James Ropa - 通讯作者:
James Ropa
Larry L Luchsinger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Larry L Luchsinger', 18)}}的其他基金
Hormetic ER Stress Regulation of Hematopoietic Stem Cell Function
造血干细胞功能的激效内质网应激调节
- 批准号:
10299328 - 财政年份:2021
- 资助金额:
$ 49.53万 - 项目类别:
Hormetic ER Stress Regulation of Hematopoietic Stem Cell Function
造血干细胞功能的激效内质网应激调节
- 批准号:
10437876 - 财政年份:2021
- 资助金额:
$ 49.53万 - 项目类别:
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
$ 49.53万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
- 批准号:
2222215 - 财政年份:2023
- 资助金额:
$ 49.53万 - 项目类别:
Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
- 批准号:
23K09272 - 财政年份:2023
- 资助金额:
$ 49.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
- 批准号:
10652764 - 财政年份:2023
- 资助金额:
$ 49.53万 - 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
- 批准号:
10730652 - 财政年份:2023
- 资助金额:
$ 49.53万 - 项目类别:
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
- 批准号:
22K11609 - 财政年份:2022
- 资助金额:
$ 49.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
- 批准号:
22K16720 - 财政年份:2022
- 资助金额:
$ 49.53万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
- 批准号:
RGPIN-2018-04107 - 财政年份:2022
- 资助金额:
$ 49.53万 - 项目类别:
Discovery Grants Program - Individual
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
- 批准号:
RGPIN-2019-05674 - 财政年份:2022
- 资助金额:
$ 49.53万 - 项目类别:
Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
- 批准号:
22K12824 - 财政年份:2022
- 资助金额:
$ 49.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)